Related Experiment Video
Updated: Jul 11, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
Published on: September 16, 2020
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation
Lei Ying1, Anne B Hofseth, Darren D Browning
1Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, School of Medicine, University of South Carolina, Columbia, South Carolina 29208, USA.
Abstract:
Patients with chronic inflammatory bowel disease have a high risk of colon cancer. The molecules that initiate and promote colon cancer and the cancer pathways altered remain undefined. Here, using in vitro models and a mouse model of colitis, we show that nitric oxide (NO) species induce retinoblastoma protein (pRb) hyperphosphorylation and inactivation, resulting in increased proliferation through the pRb-E2F1 pathway. NO-driven pRb hyperphosphorylation occurs through soluble guanylyl cyclase/guanosine 3',5'-cyclic monophosphate signaling and is dependent on the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase MEK/ERK and phosphatidylinositol 3-kinase/AKT pathways. Our results reveal a link between NO and pRb inactivation and provide insight into molecules that can be targeted in the prevention of the inflammation-to-cancer sequence.
Insights
Nitric oxide (NO) species promote colon cancer in inflammatory bowel disease by inactivating the retinoblastoma protein (pRb), increasing cell proliferation. This NO-driven pathway offers potential targets for preventing inflammation-induced cancer.
Area of Science:
- Gastroenterology
- Molecular Biology
- Cancer Research
Background:
- Patients with chronic inflammatory bowel disease (IBD) face an elevated risk of colon cancer.
- The specific molecular mechanisms driving colon cancer initiation and progression in IBD remain largely unknown.
Purpose of the Study:
- To elucidate the molecular pathways linking inflammation to colon cancer in IBD.
- To identify key molecules involved in the inflammation-to-cancer sequence.
Main Methods:
- Utilized in vitro cell models and a mouse model of colitis.
- Investigated the role of nitric oxide (NO) species in cellular proliferation and protein regulation.
Main Results:
- Nitric oxide (NO) species were found to induce hyperphosphorylation and inactivation of the retinoblastoma protein (pRb).
- This inactivation activates the pRb-E2F1 pathway, leading to increased cell proliferation.
- NO-driven pRb hyperphosphorylation is mediated by soluble guanylyl cyclase/cyclic GMP signaling and involves MEK/ERK and PI3K/AKT pathways.
Conclusions:
- Established a direct link between nitric oxide (NO) and the inactivation of retinoblastoma protein (pRb).
- Identified specific signaling pathways (sGC/cGMP, MEK/ERK, PI3K/AKT) involved in NO-induced pRb inactivation.
- Provided crucial insights into molecular targets for preventing colon cancer in the context of chronic inflammation.
Related Concept Videos
Nitric Oxide Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway

